Gian Paolo Dagrada

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (12)

Marta Barisella

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Sandro Pasquali

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Luigi Mariani

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Rihan El Bezawy

Open University

UNITED KINGDOM

View details

Giancarlo Pruneri

University of Milan

ITALY

View details

Alessia Bertolotti

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Adele Busico

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Antonella Brunello

Istituto Oncologico Veneto IOV-IRCCS

ITALY

View details

Silvia Damian

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Paola Collini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Claudia Sangalli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Fabio Bozzi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gian Paolo Dagrada

Research Interests

Explore related searches

Contact this professor

Articles (10)

Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft

Long-term survivors with desmoplastic small round cell tumor (DSRCT): Results from a retrospective single-institution case series analysis.

A spindle cell neoplasm with MYH9::EGFR fusion and co-expression of S100 and CD34, further expanding the family of kinase fusion positive spindle cell neoplasms.

ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).

Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples

Expression of p53 as a biomarker of pazopanib efficacy in solitary fibrous tumours: translational analysis of a phase II trial.

NR4A3 fusion molecular profile change pathological diagnosis? A case report.

Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation.

The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification

Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian rare cancer network

Collaborators (12)

Marta Barisella

Sandro Pasquali

Luigi Mariani

Rihan El Bezawy

Giancarlo Pruneri

Alessia Bertolotti

Adele Busico

Antonella Brunello

Silvia Damian

Paola Collini

Claudia Sangalli

Fabio Bozzi

Make your next move.